8/5/2026, 2:30:03 pm

Contract Manufacturing Orders See Strong Recovery in FY26's Second Half

India’s CDMO sector witnessed improved order inflows in the second half of FY26, driven by a rebound in biotech funding, inventory normalization and higher outsourcing of late-stage programs. Companies including Piramal Pharma, Syngene International and Laurus Labs reported stronger client engagement, broader recovery trends and growing demand for integrated and complex CDMO capabilities.